Latov, Norman
Article History
First Online: 1 July 2014
Change Date: 8 July 2014
Change Type: Correction
Change Details: In the version of the 'key points' originally posted online, the word 'demyelinating' was missing from the third point. The third point should read "If no other cause is found, chronic demyelinating neuropathies are diagnosed as chronic inflammatory demyelinating polyneuropathy (CIDP), whereas chronic axonal neuropathies are considered idiopathic, and have no available treatment." The error has been corrected in the online PDF and HTML versions of the article.
Competing interests
: The author has consulted for Oncogenex Pharmaceuticals, Novartis Pharma, XenoPort, CSL Behring, Baxter Healthcare, Sumitomo Pharma, Merck, and OncoGenex, owns stock in Therapath LLC, and has received a research grant to Cornell University from Grifols.